nav bg

연구데이터 > 검색

[논문] Gamma-aminobutyric acid (GABA)-mediated bone formation and its implications for anti-osteoporosis strategies: Exploring the relation between GABA and GABA receptors

메타 데이터

세부정보 닫기열기
세부과제책임자

김기영

논문제목(Title)

[논문] Gamma-aminobutyric acid (GABA)-mediated bone formation and its implications for anti-osteoporosis strategies: Exploring the relation between GABA and GABA receptors

학술지명(Journal)

Biochemical Pharmacology

ImpactFactor

5.8

ISSN_ISBN

0006-2952

학술지볼륨권호(Volume)

218

SCI구분

SCIE

초록(Abstract)

Osteoporosis is a significant global health concern, linked to reduced bone density and an increased fracture risk, with effective treatments still lacking. This study explored the potential of gamma-aminobutyric acid (GABA) and its receptors as a novel approach to promote osteogenesis and address osteoporosis. GABA concentrations up to 10 mM were well-tolerated by MC3T3-E1 preosteoblast, stimulating osteoblast differentiation and mineralization in a concentration- and time-dependent manner. In vivo experiments with zebrafish larvae demonstrated the ability of GABA to improve vertebral formation and enhanced bone density, indicating the potential therapeutic value for osteoporosis. Notably, GABA countered the adverse effects of prednisolone on vertebral formation, bone density, and osteogenic gene expression in zebrafish larvae, suggesting a promising therapeutic solution to counteract corticosteroid-induced osteoporosis. Moreover, our study highlighted the involvement of GABA receptors in mediating the observed osteogenic effects. By using GABAA, GABAB, and GABAC receptor antagonists, we demonstrated that blocking these receptors attenuated GABA-induced osteoblast differentiation and vertebral formation in both MC3T3-E1 cells and zebrafish larvae, underscoring the importance of GABA receptor interactions in promoting bone formation. In conclusion, these findings underscore the osteogenic potential of GABA and its ability to mitigate the detrimental effects of corticosteroids on bone health. Targeting GABA and its receptors could be a promising strategy for the development of novel therapeutic interventions to address osteoporosis. However, further investigations are warranted to fully elucidate the underlying molecular mechanism of GABA and its clinical applications in treating osteoporosis.

저자명(Author)

Wisurumuni Arachchilage Hasitha Maduranga Karunarathne, Yung Hyun Choi, Mi-Hwa Lee, Chang-Hee Kang, Gi-Young Kim

학술지출판일자(PublicationDate)

2023.10.29

DMP

과제명(영문)

Canonical and noncanonical NLRP3 inflammasome activation by bisphenol A

연구책임자 / 소속

김기영 / 해양생명과학과

당해연구기간

2023.03.01-2024.02.29

공개 및 라이선스

공개 일자

2023-12-07

라이선스

저작자표시-비영리

저작권

이 데이터의 저작권은 <연구자 기관/그룹/사용자>에게 있습니다.

  • 293views
  • 0downloads
컬렉션
[김기영] 비스페놀A의 NLRP3 inflammasome을 통한 염증유도(2023)
제출자
관리자
공개일자
2023-12-07
Versions
  • Version 1 2023-12-07
Cite as
Wisurumuni Arachchilage Hasitha Maduranga Karunarathne, Yung Hyun Choi, Mi-Hwa Lee, Chang-Hee Kang, Gi-Young Kim, 2023.10.29, [논문] Gamma-aminobutyric acid (GABA)-mediated bone formation and its implications for anti-osteoporosis strategies: Exploring the relation between GABA and GABA receptors
Export